Business Description
Bionime Corp
NAICS : 541711
SIC : 8731
ISIN : TW0004737002
Description
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's products include blood glucose monitoring devices, Lancing devices, Testing Strips, and blood glucose testing chips which are applied in the testing and monitoring of blood glucose density.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 1.6 | |||||
| Debt-to-EBITDA | 40.27 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.87 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.2 | |||||
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year FCF Growth Rate | -43.8 | |||||
| 3-Year Book Growth Rate | -1.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.66 | |||||
| 9-Day RSI | 28.23 | |||||
| 14-Day RSI | 32.9 | |||||
| 6-1 Month Momentum % | -0.14 | |||||
| 12-1 Month Momentum % | -7.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 165.27 | |||||
| Days Sales Outstanding | 98.98 | |||||
| Days Payable | 52.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.06 | |||||
| 3-Year Dividend Growth Rate | 1.8 | |||||
| Forward Dividend Yield % | 3.06 | |||||
| 5-Year Yield-on-Cost % | 1.9 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -8.07 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.46 | |||||
| Operating Margin % | -6.57 | |||||
| Net Margin % | -4.33 | |||||
| FCF Margin % | -9.01 | |||||
| ROE % | -4.35 | |||||
| ROA % | -1.56 | |||||
| ROIC % | -1.29 | |||||
| ROC (Joel Greenblatt) % | -3.03 | |||||
| ROCE % | -2.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 55.04 | |||||
| Shiller PE Ratio | 35.04 | |||||
| PS Ratio | 2.13 | |||||
| PB Ratio | 2.16 | |||||
| Price-to-Tangible-Book | 3.61 | |||||
| Price-to-Operating-Cash-Flow | 21.85 | |||||
| EV-to-EBIT | -63 | |||||
| EV-to-EBITDA | 89.06 | |||||
| EV-to-Revenue | 3.4 | |||||
| EV-to-FCF | -37.66 | |||||
| Price-to-Projected-FCF | 5.68 | |||||
| Price-to-Median-PS-Value | 1.02 | |||||
| Earnings Yield (Greenblatt) % | -1.59 | |||||
| FCF Yield % | -4.38 | |||||
| Forward Rate of Return (Yacktman) % | -18.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionime Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,921.187 | ||
| EPS (TTM) (NT$) | -1.36 | ||
| Beta | 0.38 | ||
| Volatility % | 14.11 | ||
| 14-Day RSI | 32.9 | ||
| 14-Day ATR (NT$) | 0.705432 | ||
| 20-Day SMA (NT$) | 66.84 | ||
| 12-1 Month Momentum % | -7.88 | ||
| 52-Week Range (NT$) | 60.8 - 76.6 | ||
| Shares Outstanding (Mil) | 60.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionime Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionime Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bionime Corp Frequently Asked Questions
What is Bionime Corp(TPE:4737)'s stock price today?
The current price of TPE:4737 is NT$65.00. The 52 week high of TPE:4737 is NT$76.60 and 52 week low is NT$60.80.
When is next earnings date of Bionime Corp(TPE:4737)?
The next earnings date of Bionime Corp(TPE:4737) is .
Does Bionime Corp(TPE:4737) pay dividends? If so, how much?
The Dividend Yield %  of Bionime Corp(TPE:4737) is 3.06% (As of Today), Highest Dividend Payout Ratio of Bionime Corp(TPE:4737) was 21. The lowest was 0.21. And the median was 1.26. The  Forward Dividend Yield % of Bionime Corp(TPE:4737) is 3.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers